FAM83A may serve as a potential prognostic indicator for stomach adenocarcinoma.

ABSTRACT:

Background

Currently, gastric cancer clinical biomarkers are susceptible to interference, causing low specificity or sensitivity. Some also fail to reflect molecular heterogeneity and predict prognosis individually, so urgent clinical need exists for new biomarkers. FAM83A is a member of the family with sequence similarity 83 (FAM83) family, which could predict the prognosis of lung adenocarcinoma (LUAD). However, the relationship between FAM83A and stomach adenocarcinoma (STAD) prognosis remains unclear. Therefore, this study aims to investigate the expression of FAM83A in STAD and its role in predicting prognosis, with the aim of providing novel potential prognostic biomarkers for clinical practice.

Methods

We obtained The Cancer Genome Atlas (TCGA)/Genotype-Tissue Express

SUBMITTER: Song DF 

PROVIDER: S-EPMC12554509 | biostudies-literature | 2025 Sep

REPOSITORIES: biostudies-literature